GAT: Clinical Trials

1 trial of GAT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow GAT: new trials by email Literature Review of GAT trials Research Report on GAT

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors
First part: Gatipotuzumab and Tomuzotuximab; Second part: Gatipotuzumab and Tomuzotuximab or anti-EGFR antibody (Cetuximab, Panitumumab or Necitumumab) - Solid Tumor, Adult
Phase 1CompletedGlycotope GmbH502017-11-022021-07-12

Sponsors

Glycotope GmbH (1)

Countries

Germany (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Sebastian Ochsenreither, Dr. med. (1)

Results publications

PMID 35397434

NIH funding

2017 (1)